Showing results (1-10 of 9) with videos related to
Sort By:
Pageof 1
Expert Review of Anticancer Therapy|October 12, 2020
Pembrolizumab and other immune checkpoint inhibitors in locally advanced or metastatic Merkel Cell Carcinoma: safety and efficacyAntoine Marchand, Thibault Kervarrec, Shailender Bhatia, et al.Cells|September 28, 2021
Alpha-Synuclein and Lipids: The Elephant in the Room?Alessia Sarchione, Antoine Marchand, Jean-Marc Taymans, et al.Current Oncology Reports|June 2, 2023
Cured or Not? Long-term Outcomes of Immunotherapy Responders. Focus on MelanomaCéline Boutros, Djaouida Belkadi-Sadou, Antoine Marchand, et al.Frontiers in Neuroscience|July 3, 2020
LRRK2 Phosphorylation, More Than an EpiphenomenonAntoine Marchand, Matthieu Drouyer, Alessia Sarchione, et al.Ecology and Evolution|May 12, 2021
Determinants of habitat suitability models transferability across geographically disjunct populations: Insights from Vipera ursinii urs iniiFrancesco Cerasoli, Aurélien Besnard, Marc-Antoine Marchand, et al.Journal De Mycologie Medicale|December 2, 2023
Deep-seated dermatophytosis caused by Trichophyton rubrum in patient with Becker muscular dystrophyIlham Ouaaziz, Antoine Marchand, Sophie Leducq, et al.NPJ Parkinson'S Disease|February 7, 2023
Alterations in the LRRK2-Rab pathway in urinary extracellular vesicles as Parkinson's disease and pharmacodynamic biomarkersJean-Marc Taymans, Eugénie Mutez, William Sibran, et al.Movement Disorders : Official Journal of the Movement Disorder Society|June 16, 2022
Functional Analyses of Two Novel LRRK2 Pathogenic Variants in Familial Parkinson's DiseaseIlda Coku, Eugénie Mutez, Sabiha Eddarkaoui, et al.Cells|March 25, 2022
A Phosphosite Mutant Approach on LRRK2 Links Phosphorylation and Dephosphorylation to Protective and Deleterious Markers, RespectivelyAntoine Marchand, Alessia Sarchione, Panagiotis S Athanasopoulos, et al.Pageof 1